Anti-inflammatory drugs did not speed COVID-19 recovery but

Two drugs commonly used to treat inflammatory diseases such as rheumatoid arthritis and psoriasis did not shorten recovery time for patients hospitalized with severe COVID-19 but did reduce the likelihood of death when compared with standard care alone, according to a study led by the Washington University School of Medicine in St. Louis.

Related Keywords

United States , America , Williamg Powderly , J William Campbell , , Washington University School Of Medicine , National Institutes Of Health , Human Services , Translational Sciences , Administration For Strategic Preparedness , Development Authority , Translational Science Awards Program , Biomedical Advanced Research , National Center , Us Department Of Health , Washington University School , Strategic Preparedness , Advancing Translational Sciences , National Institutes , Campbell Professor , Infectious Diseases ,